MICHAEL S. O'REILLY, M.D.
Radiology at Holcombe Blvd, Houston, TX
License number
Texas L4083
Category
Radiology
Type
Radiation Oncology
Address
Address
1515 Holcombe Blvd, Houston, TX 77030
Phone
(713) 792-6161
(713) 792-2991
(713) 792-2991
Personal information
See more information about MICHAEL S. O'REILLY at radaris.comName
Address
Phone
7520 Hornwood Dr APT 906W, Houston, TX 77036
710 White Dr, Garland, TX 75040
12903 Westhorpe Dr, Houston, TX 77077
Houston, TX
Fresno, TX
Professional information
See more information about MICHAEL S. O'REILLY at trustoria.com
Dr. Michael S O'reilly, Houston TX - MD (Doctor of Medicine)
Dr. Michael S O'reilly, Houston TX - MD (Doctor of Medicine)
Specialties:
Radiation Oncology
Address:
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
(713) 792-2121 (Phone)
1515 Holcombe Blvd, Houston 77030
(713) 792-2121 (Phone), (713) 794-5492 (Fax)
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
(713) 792-2121 (Phone)
Certifications:
Radiation Oncology, 2000
Awards:
Healthgrades Honor Roll
Languages:
English, French
Hospitals:
MD ANDERSON CANCER CENTER
1515 Holcombe Blvd, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
1515 Holcombe Blvd, Houston 77030
MD Anderson Cancer Center
1515 Holcombe Blvd SUITE 207, Houston 77030
The University of Texas M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston 77030
Education:
Medical School
Tufts University School Of Medicine
University Mass Med Center
Graduated: 1991
Joint Center For Rad Therapy
Graduated: 2000
Harvard Med School
Graduated: 1996
Tufts University School Of Medicine
University Mass Med Center
Graduated: 1991
Joint Center For Rad Therapy
Graduated: 2000
Harvard Med School
Graduated: 1996
Michael Scott O'Reilly, Houston TX
Michael Scott O'Reilly, Houston TX
Specialties:
Radiology, Radiation Oncology, Medical Oncology
Work:
M.D. Anderson Cancer Center
1515 Holcombe Blvd, Houston, TX 77030
1515 Holcombe Blvd, Houston, TX 77030
Education:
Tufts University (1989)
Michael S O'Reilly, Houston TX
Michael S O'Reilly, Houston TX
Specialties:
Oncologist
Address:
1515 Holcombe Blvd, Houston, TX 77030
Education:
Doctor of Medicine
Nucleic Acids Encoding Plasminogen Fragments And Methods Of Use
Nucleic Acids Encoding Plasminogen Fragments And Methods Of Use
US Patent:
7485439, Feb 3, 2009
Filed:
Apr 22, 2002
Appl. No.:
10/127066
Inventors:
M. Judah Folkman - Newton MA, US
Michael S. O'Reilly - Houston TX, US
Yihai Cao - Stockholm, SE
Kim Lee Sim - Gaithersburg MD, US
Michael S. O'Reilly - Houston TX, US
Yihai Cao - Stockholm, SE
Kim Lee Sim - Gaithersburg MD, US
Assignee:
The Children's Medical Center Corporation - Boston MA
International Classification:
C12P 21/06, C07H 21/02
US Classification:
435 691, 4353201, 4352523, 435325, 536 231
Abstract:
Nucleic acid sequence encoding kringle region fragment of plasminogen vectors comprising such nucleic acid, and methods of use of such nucleic acids, Ribonucleic and deoxyribonucleic acid sequence that encode for kringle region fragments are useful for gene therapy or recombinant expression for the treatment of angiogenesis-related diseases, specifically angiogenesis-dependent cancer.
Plasminogen-Related Gene B Polypeptides
Plasminogen-Related Gene B Polypeptides
US Patent:
2002015, Oct 17, 2002
Filed:
May 7, 2001
Appl. No.:
09/850564
Inventors:
Lawrence Weissbach - Boston MA, US
Valerae Lewis - Houston TX, US
Michael O'Reilly - Houston TX, US
Valerae Lewis - Houston TX, US
Michael O'Reilly - Houston TX, US
International Classification:
A61K048/00, A61K038/17
US Classification:
514/012000, 514/044000
Abstract:
A method of inhibiting angiogenesis or neoplastic growth, or both, in a bird or mammal is disclosed. The method involves identifying an animal that has, or is at risk for, unwanted angiogenesis or neoplastic growth or both, and administering to the animal an amount of a plasminogen-related gene-B polypeptide sufficient to inhibit the angiogenesis or neoplastic growth.